235 related articles for article (PubMed ID: 8991073)
1. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure.
Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ
Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073
[TBL] [Abstract][Full Text] [Related]
2. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
3. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
Recio L; Pluta LJ; Meyer KG
Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
[TBL] [Abstract][Full Text] [Related]
4. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
5. Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo.
Recio L; Bond JA; Pluta LJ; Sisk SC
IARC Sci Publ; 1993; (127):235-43. PubMed ID: 8070869
[TBL] [Abstract][Full Text] [Related]
6. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
[TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene.
Sisk SC; Pluta LJ; Bond JA; Recio L
Carcinogenesis; 1994 Mar; 15(3):471-7. PubMed ID: 8118931
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity and mutational spectra of 1,3-butadiene in the bone marrow of B6C3F1 lacI transgenic mice.
Recio L; Sisk S; Meyer K; Pluta L; Bond JA
Toxicology; 1996 Oct; 113(1-3):106-11. PubMed ID: 8901889
[TBL] [Abstract][Full Text] [Related]
12. Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene.
Meng Q; Walker DM; McDonald JD; Henderson RF; Carter MM; Cook DL; McCash CL; Torres SM; Bauer MJ; Seilkop SK; Upton PB; Georgieva NI; Boysen G; Swenberg JA; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):121-31. PubMed ID: 16945358
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lacI transgenic mice exposed to 1,3-butadiene.
Recio L; Meyer KG
Environ Mol Mutagen; 1995; 26(1):1-8. PubMed ID: 7641703
[TBL] [Abstract][Full Text] [Related]
14. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
15. In vivo mutagenicity and mutation spectrum in the bone marrow and testes of B6C3F1 lacI transgenic mice following inhalation exposure to ethylene oxide.
Recio L; Donner M; Abernethy D; Pluta L; Steen AM; Wong BA; James A; Preston RJ
Mutagenesis; 2004 May; 19(3):215-22. PubMed ID: 15123787
[TBL] [Abstract][Full Text] [Related]
16. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis.
Provost GS; Mirsalis JC; Rogers BJ; Short JM
Environ Mol Mutagen; 1996; 28(4):342-7. PubMed ID: 8991062
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of mutations in kidney, stomach, and liver from lacI transgenic mice recovered after treatment with tris(2,3-dibromopropyl)phosphate.
de Boer JG; Mirsalis JC; Provost GS; Tindall KR; Glickman BW
Environ Mol Mutagen; 1996; 28(4):418-23. PubMed ID: 8991072
[TBL] [Abstract][Full Text] [Related]
19. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice.
Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T
Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063
[TBL] [Abstract][Full Text] [Related]
20. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]